nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR1F—trigeminal nerve—head and neck cancer	0.113	0.214	CbGeAlD
Methysergide—HTR7—superior cervical ganglion—head and neck cancer	0.0632	0.12	CbGeAlD
Methysergide—HTR1B—trigeminal nerve—head and neck cancer	0.0463	0.0878	CbGeAlD
Methysergide—HTR1D—trigeminal nerve—head and neck cancer	0.0449	0.085	CbGeAlD
Methysergide—Telangiectasia—Fluorouracil—head and neck cancer	0.0353	0.0746	CcSEcCtD
Methysergide—HTR1B—cranial nerve—head and neck cancer	0.033	0.0626	CbGeAlD
Methysergide—HTR1D—cranial nerve—head and neck cancer	0.032	0.0606	CbGeAlD
Methysergide—HTR7—cranial nerve—head and neck cancer	0.0255	0.0483	CbGeAlD
Methysergide—HTR2A—trigeminal nerve—head and neck cancer	0.0223	0.0422	CbGeAlD
Methysergide—Gastrointestinal symptom NOS—Hydroxyurea—head and neck cancer	0.0196	0.0416	CcSEcCtD
Methysergide—HTR2A—cranial nerve—head and neck cancer	0.0159	0.0301	CbGeAlD
Methysergide—Gastrointestinal symptom NOS—Fluorouracil—head and neck cancer	0.0141	0.0299	CcSEcCtD
Methysergide—Heartburn—Fluorouracil—head and neck cancer	0.0121	0.0256	CcSEcCtD
Methysergide—Blood urea increased—Hydroxyurea—head and neck cancer	0.0109	0.0231	CcSEcCtD
Methysergide—HTR1F—head—head and neck cancer	0.0098	0.0186	CbGeAlD
Methysergide—Heartburn—Docetaxel—head and neck cancer	0.00872	0.0184	CcSEcCtD
Methysergide—HTR7—mouth—head and neck cancer	0.00857	0.0163	CbGeAlD
Methysergide—HTR1E—head—head and neck cancer	0.00849	0.0161	CbGeAlD
Methysergide—Pleural effusion—Docetaxel—head and neck cancer	0.00783	0.0166	CcSEcCtD
Methysergide—HTR7—neck—head and neck cancer	0.00733	0.0139	CbGeAlD
Methysergide—Euphoric mood—Fluorouracil—head and neck cancer	0.00714	0.0151	CcSEcCtD
Methysergide—SIGMAR1—parotid gland—head and neck cancer	0.00699	0.0132	CbGeAlD
Methysergide—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00697	0.0147	CcSEcCtD
Methysergide—Dysuria—Hydroxyurea—head and neck cancer	0.00677	0.0143	CcSEcCtD
Methysergide—Neutropenia—Hydroxyurea—head and neck cancer	0.00677	0.0143	CcSEcCtD
Methysergide—SIGMAR1—saliva-secreting gland—head and neck cancer	0.00669	0.0127	CbGeAlD
Methysergide—HTR6—head—head and neck cancer	0.00666	0.0126	CbGeAlD
Methysergide—HTR1D—connective tissue—head and neck cancer	0.00659	0.0125	CbGeAlD
Methysergide—Weight increased—Hydroxyurea—head and neck cancer	0.00659	0.014	CcSEcCtD
Methysergide—Oliguria—Docetaxel—head and neck cancer	0.00651	0.0138	CcSEcCtD
Methysergide—Drowsiness—Hydroxyurea—head and neck cancer	0.00646	0.0137	CcSEcCtD
Methysergide—Ataxia—Fluorouracil—head and neck cancer	0.00567	0.012	CcSEcCtD
Methysergide—Alopecia—Vinblastine—head and neck cancer	0.00562	0.0119	CcSEcCtD
Methysergide—Lightheadedness—Docetaxel—head and neck cancer	0.00537	0.0114	CcSEcCtD
Methysergide—HTR7—connective tissue—head and neck cancer	0.00525	0.00996	CbGeAlD
Methysergide—Eosinophilia—Fluorouracil—head and neck cancer	0.00516	0.0109	CcSEcCtD
Methysergide—SIGMAR1—trachea—head and neck cancer	0.00516	0.00978	CbGeAlD
Methysergide—Ill-defined disorder—Vinblastine—head and neck cancer	0.00513	0.0109	CcSEcCtD
Methysergide—Alopecia—Hydroxyurea—head and neck cancer	0.00512	0.0108	CcSEcCtD
Methysergide—Thrombophlebitis—Docetaxel—head and neck cancer	0.00503	0.0106	CcSEcCtD
Methysergide—Malaise—Vinblastine—head and neck cancer	0.00499	0.0106	CcSEcCtD
Methysergide—HTR7—epithelium—head and neck cancer	0.00499	0.00945	CbGeAlD
Methysergide—Convulsion—Vinblastine—head and neck cancer	0.00479	0.0101	CcSEcCtD
Methysergide—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00468	0.00991	CcSEcCtD
Methysergide—Discomfort—Vinblastine—head and neck cancer	0.00465	0.00985	CcSEcCtD
Methysergide—HTR2A—neck—head and neck cancer	0.00457	0.00866	CbGeAlD
Methysergide—Malaise—Hydroxyurea—head and neck cancer	0.00455	0.00963	CcSEcCtD
Methysergide—Thrombocytopenia—Vinblastine—head and neck cancer	0.00442	0.00936	CcSEcCtD
Methysergide—HTR7—trachea—head and neck cancer	0.00441	0.00836	CbGeAlD
Methysergide—Convulsion—Hydroxyurea—head and neck cancer	0.00437	0.00926	CcSEcCtD
Methysergide—Pain in extremity—Docetaxel—head and neck cancer	0.00435	0.00922	CcSEcCtD
Methysergide—Discomfort—Hydroxyurea—head and neck cancer	0.00425	0.00899	CcSEcCtD
Methysergide—Oedema—Hydroxyurea—head and neck cancer	0.00412	0.00872	CcSEcCtD
Methysergide—Ataxia—Docetaxel—head and neck cancer	0.00409	0.00867	CcSEcCtD
Methysergide—SIGMAR1—thyroid gland—head and neck cancer	0.00408	0.00774	CbGeAlD
Methysergide—HTR2B—thyroid gland—head and neck cancer	0.00407	0.00772	CbGeAlD
Methysergide—Paraesthesia—Vinblastine—head and neck cancer	0.00406	0.00858	CcSEcCtD
Methysergide—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00403	0.00854	CcSEcCtD
Methysergide—HTR1B—head—head and neck cancer	0.00401	0.00761	CbGeAlD
Methysergide—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00398	0.00842	CcSEcCtD
Methysergide—HTR1D—head—head and neck cancer	0.00389	0.00737	CbGeAlD
Methysergide—Pain—Vinblastine—head and neck cancer	0.00386	0.00817	CcSEcCtD
Methysergide—Constipation—Vinblastine—head and neck cancer	0.00386	0.00817	CcSEcCtD
Methysergide—HTR2C—head—head and neck cancer	0.00385	0.00729	CbGeAlD
Methysergide—Feeling abnormal—Vinblastine—head and neck cancer	0.00372	0.00788	CcSEcCtD
Methysergide—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00369	0.00782	CcSEcCtD
Methysergide—Alopecia—Fluorouracil—head and neck cancer	0.00369	0.00781	CcSEcCtD
Methysergide—Dyspnoea—Hydroxyurea—head and neck cancer	0.00367	0.00777	CcSEcCtD
Methysergide—Somnolence—Hydroxyurea—head and neck cancer	0.00366	0.00775	CcSEcCtD
Methysergide—Dyspepsia—Hydroxyurea—head and neck cancer	0.00363	0.00767	CcSEcCtD
Methysergide—HTR2B—head—head and neck cancer	0.00361	0.00685	CbGeAlD
Methysergide—Abdominal pain—Vinblastine—head and neck cancer	0.00357	0.00756	CcSEcCtD
Methysergide—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00356	0.00753	CcSEcCtD
Methysergide—Fatigue—Hydroxyurea—head and neck cancer	0.00355	0.00752	CcSEcCtD
Methysergide—Constipation—Hydroxyurea—head and neck cancer	0.00352	0.00746	CcSEcCtD
Methysergide—Pain—Hydroxyurea—head and neck cancer	0.00352	0.00746	CcSEcCtD
Methysergide—Neutropenia—Docetaxel—head and neck cancer	0.00352	0.00745	CcSEcCtD
Methysergide—Weight increased—Docetaxel—head and neck cancer	0.00342	0.00725	CcSEcCtD
Methysergide—Weight decreased—Docetaxel—head and neck cancer	0.0034	0.00721	CcSEcCtD
Methysergide—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00339	0.00718	CcSEcCtD
Methysergide—HTR2A—connective tissue—head and neck cancer	0.00328	0.00621	CbGeAlD
Methysergide—Body temperature increased—Hydroxyurea—head and neck cancer	0.00326	0.00689	CcSEcCtD
Methysergide—Asthenia—Vinblastine—head and neck cancer	0.00324	0.00686	CcSEcCtD
Methysergide—HTR1A—head—head and neck cancer	0.00324	0.00614	CbGeAlD
Methysergide—Convulsion—Fluorouracil—head and neck cancer	0.00315	0.00666	CcSEcCtD
Methysergide—HTR2A—epithelium—head and neck cancer	0.00311	0.0059	CbGeAlD
Methysergide—HTR7—head—head and neck cancer	0.0031	0.00587	CbGeAlD
Methysergide—Chest pain—Fluorouracil—head and neck cancer	0.00309	0.00655	CcSEcCtD
Methysergide—Myalgia—Fluorouracil—head and neck cancer	0.00309	0.00655	CcSEcCtD
Methysergide—Diarrhoea—Vinblastine—head and neck cancer	0.00309	0.00654	CcSEcCtD
Methysergide—Discomfort—Fluorouracil—head and neck cancer	0.00306	0.00647	CcSEcCtD
Methysergide—Dizziness—Vinblastine—head and neck cancer	0.00299	0.00632	CcSEcCtD
Methysergide—Oedema peripheral—Docetaxel—head and neck cancer	0.00297	0.00628	CcSEcCtD
Methysergide—Oedema—Fluorouracil—head and neck cancer	0.00296	0.00628	CcSEcCtD
Methysergide—Asthenia—Hydroxyurea—head and neck cancer	0.00296	0.00626	CcSEcCtD
Methysergide—Thrombocytopenia—Fluorouracil—head and neck cancer	0.0029	0.00614	CcSEcCtD
Methysergide—Tachycardia—Fluorouracil—head and neck cancer	0.00289	0.00612	CcSEcCtD
Methysergide—Vomiting—Vinblastine—head and neck cancer	0.00287	0.00608	CcSEcCtD
Methysergide—Diarrhoea—Hydroxyurea—head and neck cancer	0.00282	0.00597	CcSEcCtD
Methysergide—Flushing—Docetaxel—head and neck cancer	0.0028	0.00592	CcSEcCtD
Methysergide—HTR2A—trachea—head and neck cancer	0.00275	0.00521	CbGeAlD
Methysergide—Dizziness—Hydroxyurea—head and neck cancer	0.00272	0.00577	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.0027	0.00572	CcSEcCtD
Methysergide—Nausea—Vinblastine—head and neck cancer	0.00268	0.00568	CcSEcCtD
Methysergide—Insomnia—Fluorouracil—head and neck cancer	0.00268	0.00568	CcSEcCtD
Methysergide—Paraesthesia—Fluorouracil—head and neck cancer	0.00266	0.00563	CcSEcCtD
Methysergide—Alopecia—Docetaxel—head and neck cancer	0.00266	0.00563	CcSEcCtD
Methysergide—Dyspnoea—Fluorouracil—head and neck cancer	0.00264	0.00559	CcSEcCtD
Methysergide—Somnolence—Fluorouracil—head and neck cancer	0.00264	0.00558	CcSEcCtD
Methysergide—Vomiting—Hydroxyurea—head and neck cancer	0.00262	0.00554	CcSEcCtD
Methysergide—Dyspepsia—Fluorouracil—head and neck cancer	0.00261	0.00552	CcSEcCtD
Methysergide—Rash—Hydroxyurea—head and neck cancer	0.0026	0.0055	CcSEcCtD
Methysergide—Dermatitis—Hydroxyurea—head and neck cancer	0.00259	0.00549	CcSEcCtD
Methysergide—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00256	0.00542	CcSEcCtD
Methysergide—SIGMAR1—lymph node—head and neck cancer	0.00254	0.00481	CbGeAlD
Methysergide—Back pain—Docetaxel—head and neck cancer	0.00254	0.00537	CcSEcCtD
Methysergide—Pain—Fluorouracil—head and neck cancer	0.00254	0.00537	CcSEcCtD
Methysergide—HTR2B—lymph node—head and neck cancer	0.00253	0.0048	CbGeAlD
Methysergide—Nausea—Hydroxyurea—head and neck cancer	0.00245	0.00518	CcSEcCtD
Methysergide—Feeling abnormal—Fluorouracil—head and neck cancer	0.00244	0.00517	CcSEcCtD
Methysergide—Body temperature increased—Fluorouracil—head and neck cancer	0.00234	0.00496	CcSEcCtD
Methysergide—Convulsion—Docetaxel—head and neck cancer	0.00227	0.00481	CcSEcCtD
Methysergide—Chest pain—Docetaxel—head and neck cancer	0.00223	0.00472	CcSEcCtD
Methysergide—Myalgia—Docetaxel—head and neck cancer	0.00223	0.00472	CcSEcCtD
Methysergide—Arthralgia—Docetaxel—head and neck cancer	0.00223	0.00472	CcSEcCtD
Methysergide—Oedema—Docetaxel—head and neck cancer	0.00214	0.00453	CcSEcCtD
Methysergide—Thrombocytopenia—Docetaxel—head and neck cancer	0.0021	0.00443	CcSEcCtD
Methysergide—Tachycardia—Docetaxel—head and neck cancer	0.00209	0.00442	CcSEcCtD
Methysergide—Diarrhoea—Fluorouracil—head and neck cancer	0.00203	0.00429	CcSEcCtD
Methysergide—Dizziness—Fluorouracil—head and neck cancer	0.00196	0.00415	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00195	0.00413	CcSEcCtD
Methysergide—Insomnia—Docetaxel—head and neck cancer	0.00194	0.0041	CcSEcCtD
Methysergide—HTR2A—head—head and neck cancer	0.00193	0.00366	CbGeAlD
Methysergide—Paraesthesia—Docetaxel—head and neck cancer	0.00192	0.00407	CcSEcCtD
Methysergide—Dyspnoea—Docetaxel—head and neck cancer	0.00191	0.00404	CcSEcCtD
Methysergide—Somnolence—Docetaxel—head and neck cancer	0.0019	0.00403	CcSEcCtD
Methysergide—Vomiting—Fluorouracil—head and neck cancer	0.00189	0.00399	CcSEcCtD
Methysergide—Dyspepsia—Docetaxel—head and neck cancer	0.00188	0.00399	CcSEcCtD
Methysergide—Rash—Fluorouracil—head and neck cancer	0.00187	0.00396	CcSEcCtD
Methysergide—Dermatitis—Fluorouracil—head and neck cancer	0.00187	0.00395	CcSEcCtD
Methysergide—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00185	0.00391	CcSEcCtD
Methysergide—Fatigue—Docetaxel—head and neck cancer	0.00184	0.0039	CcSEcCtD
Methysergide—Pain—Docetaxel—head and neck cancer	0.00183	0.00387	CcSEcCtD
Methysergide—Constipation—Docetaxel—head and neck cancer	0.00183	0.00387	CcSEcCtD
Methysergide—Feeling abnormal—Docetaxel—head and neck cancer	0.00176	0.00373	CcSEcCtD
Methysergide—Nausea—Fluorouracil—head and neck cancer	0.00176	0.00373	CcSEcCtD
Methysergide—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00175	0.0037	CcSEcCtD
Methysergide—Abdominal pain—Docetaxel—head and neck cancer	0.00169	0.00358	CcSEcCtD
Methysergide—Body temperature increased—Docetaxel—head and neck cancer	0.00169	0.00358	CcSEcCtD
Methysergide—Asthenia—Docetaxel—head and neck cancer	0.00154	0.00325	CcSEcCtD
Methysergide—Diarrhoea—Docetaxel—head and neck cancer	0.00146	0.0031	CcSEcCtD
Methysergide—Dizziness—Docetaxel—head and neck cancer	0.00142	0.003	CcSEcCtD
Methysergide—Vomiting—Docetaxel—head and neck cancer	0.00136	0.00288	CcSEcCtD
Methysergide—Rash—Docetaxel—head and neck cancer	0.00135	0.00286	CcSEcCtD
Methysergide—Dermatitis—Docetaxel—head and neck cancer	0.00135	0.00285	CcSEcCtD
Methysergide—Nausea—Docetaxel—head and neck cancer	0.00127	0.00269	CcSEcCtD
